Published • loading... • Updated
Real Estate Deal: Pharmaceutical Group Novartis Sells Kundler Site Area
Summary by Tiroler Tageszeitung Online
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Innexis, operator of industrial parks, takes over from Novartis all buildings and land at the Kundl site. Novartis retains production facilities and laboratory equipment.
INNEXIS Holding GmbH & Co. KG plans to acquire the Life Science Campus in Kundl, Austria, from the internationally active biotechnology and pharmaceutical company Novartis. This transaction will allow Novartis Austria to concentrate on its core business, particularly research and development.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
